Cargando…
Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections
Biodegradable polymers, especially poly(lactide-co-glycolide) (PLGA), have good biocompatibility and toxicological properties. In combination with active ingredients, a specialized drug delivery system can be generated. The aim of the present study was to develop a drug delivery system consisting of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019313/ https://www.ncbi.nlm.nih.gov/pubmed/27660414 http://dx.doi.org/10.2147/DDDT.S105367 |
_version_ | 1782453034963435520 |
---|---|
author | Reinbold, Jochen Hierlemann, Teresa Hinkel, Helena Müller, Ingrid Maier, Martin E Weindl, Tobias Schlensak, Christian Wendel, Hans Peter Krajewski, Stefanie |
author_facet | Reinbold, Jochen Hierlemann, Teresa Hinkel, Helena Müller, Ingrid Maier, Martin E Weindl, Tobias Schlensak, Christian Wendel, Hans Peter Krajewski, Stefanie |
author_sort | Reinbold, Jochen |
collection | PubMed |
description | Biodegradable polymers, especially poly(lactide-co-glycolide) (PLGA), have good biocompatibility and toxicological properties. In combination with active ingredients, a specialized drug delivery system can be generated. The aim of the present study was to develop a drug delivery system consisting of PLGA microspheres loaded with the natural active ingredient totarol, which has several antimicrobial mechanisms. Totarol, isolated from the Podocarpus totara tree, was purified using column chromatography, and the eluate was checked for purity using thin layer chromatography. The spherically shaped microspheres with mean diameters of 147.21±3.45 µm and 131.14±3.69 µm (totarol-loaded and -unloaded microspheres, respectively) were created using the single emulsion evaporation method. Furthermore, the encapsulation efficiency, in a range of 84.72%±6.68% to 92.36%±0.99%, was measured via UV/vis spectroscopy. In a 90-day in vitro drug release study, the release of totarol was investigated by UV/vis spectroscopy as well, showing a release of 53.76%. The toxicity on cells was determined using BJ fibroblasts or Human Embryonic Kidney cells and an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, which showed no influence on the cell growth. The minimal inhibitory concentration was ascertained. A totarol concentration between 64 µg/mL and 128 µg/mL was necessary to inhibit the bacterial growth over a period of 24 hours. Biofilm formation on the surface of totarol-loaded microspheres was determined using transmission electron microscopy. No biofilm formation could be detected, even if the totarol concentration was below the minimal inhibitory concentration. The hemocompatibility investigations on various markers with fresh heparinized blood (1.5 IU/mL) showed that totarol and totarol-loaded microspheres have no influence on different blood parameters. The PLGA microspheres characterized by slow release of totarol and great entrapment efficiency represent a novel drug delivery system, which may be highly beneficial for the long-term therapy of bacterial infections. |
format | Online Article Text |
id | pubmed-5019313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-50193132016-09-22 Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections Reinbold, Jochen Hierlemann, Teresa Hinkel, Helena Müller, Ingrid Maier, Martin E Weindl, Tobias Schlensak, Christian Wendel, Hans Peter Krajewski, Stefanie Drug Des Devel Ther Original Research Biodegradable polymers, especially poly(lactide-co-glycolide) (PLGA), have good biocompatibility and toxicological properties. In combination with active ingredients, a specialized drug delivery system can be generated. The aim of the present study was to develop a drug delivery system consisting of PLGA microspheres loaded with the natural active ingredient totarol, which has several antimicrobial mechanisms. Totarol, isolated from the Podocarpus totara tree, was purified using column chromatography, and the eluate was checked for purity using thin layer chromatography. The spherically shaped microspheres with mean diameters of 147.21±3.45 µm and 131.14±3.69 µm (totarol-loaded and -unloaded microspheres, respectively) were created using the single emulsion evaporation method. Furthermore, the encapsulation efficiency, in a range of 84.72%±6.68% to 92.36%±0.99%, was measured via UV/vis spectroscopy. In a 90-day in vitro drug release study, the release of totarol was investigated by UV/vis spectroscopy as well, showing a release of 53.76%. The toxicity on cells was determined using BJ fibroblasts or Human Embryonic Kidney cells and an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, which showed no influence on the cell growth. The minimal inhibitory concentration was ascertained. A totarol concentration between 64 µg/mL and 128 µg/mL was necessary to inhibit the bacterial growth over a period of 24 hours. Biofilm formation on the surface of totarol-loaded microspheres was determined using transmission electron microscopy. No biofilm formation could be detected, even if the totarol concentration was below the minimal inhibitory concentration. The hemocompatibility investigations on various markers with fresh heparinized blood (1.5 IU/mL) showed that totarol and totarol-loaded microspheres have no influence on different blood parameters. The PLGA microspheres characterized by slow release of totarol and great entrapment efficiency represent a novel drug delivery system, which may be highly beneficial for the long-term therapy of bacterial infections. Dove Medical Press 2016-09-07 /pmc/articles/PMC5019313/ /pubmed/27660414 http://dx.doi.org/10.2147/DDDT.S105367 Text en © 2016 Reinbold et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Reinbold, Jochen Hierlemann, Teresa Hinkel, Helena Müller, Ingrid Maier, Martin E Weindl, Tobias Schlensak, Christian Wendel, Hans Peter Krajewski, Stefanie Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
title | Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
title_full | Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
title_fullStr | Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
title_full_unstemmed | Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
title_short | Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
title_sort | development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019313/ https://www.ncbi.nlm.nih.gov/pubmed/27660414 http://dx.doi.org/10.2147/DDDT.S105367 |
work_keys_str_mv | AT reinboldjochen developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT hierlemannteresa developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT hinkelhelena developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT mulleringrid developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT maiermartine developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT weindltobias developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT schlensakchristian developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT wendelhanspeter developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections AT krajewskistefanie developmentandinvitrocharacterizationofpolylactidecoglycolidemicrospheresloadedwithanantibacterialnaturaldrugforthetreatmentoflongtermbacterialinfections |